| |
| |
|
| Insider
Information: |
Satter Muneer A |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
60,789,542 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$80,943,196 |
|
|
| Total
Shares |
60,789,542 |
|
|
| Total
Value |
$80,943,196 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 8.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DFC Global Corp |
DLLR |
Director |
|
0 |
2005-01-27 |
1,193,504 |
Premium* |
|
|
HeartWare International Inc |
HTWR |
10% Owner |
2008-04-14 |
0 |
2008-07-11 |
25,150,000 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
Director |
2014-03-25 |
0 |
2017-07-05 |
3,037,042 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director, 10% Owner |
|
0 |
2018-09-17 |
0 |
Premium* |
|
|
Eledon Pharmaceuticals Ord Shs |
ELDN |
10% Owner |
2014-09-22 |
0 |
2014-09-22 |
1,771,688 |
Premium* |
|
|
Aadi Bioscience, Inc |
AADI |
Director, 10% Owner |
2017-03-15 |
0 |
2019-01-10 |
5,621,835 |
Premium* |
|
|
Aileron Therapeutics Inc |
ALRN |
See Remarks, Director |
2017-07-05 |
0 |
2021-01-08 |
16,609,449 |
Premium* |
|
|
Annexon, Inc. |
ANNX |
Director, 10% Owner |
2020-07-28 |
0 |
2023-12-26 |
7,406,024 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2019-01-04 |
4 |
B |
$2.12 |
$42,396 |
I/I |
20,000 |
5,538,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2019-01-07 |
4 |
B |
$2.18 |
$43,558 |
I/I |
20,000 |
5,558,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2019-01-08 |
4 |
B |
$2.20 |
$43,972 |
I/I |
20,000 |
5,578,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2019-01-09 |
4 |
B |
$2.39 |
$47,876 |
I/I |
20,000 |
5,598,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2019-01-10 |
4 |
B |
$2.45 |
$58,442 |
I/I |
23,818 |
5,621,835 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2017-09-14 |
4 |
B |
$4.25 |
$127,539 |
I/I |
30,000 |
11,132,277 |
2.25 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
10% Owner |
– – • |
2017-07-05 |
4 |
B |
$15.00 |
$499,995 |
I/I |
33,333 |
178,106 |
1.5 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2017-09-08 |
4 |
B |
$3.53 |
$176,615 |
I/I |
50,000 |
11,002,277 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2017-09-12 |
4 |
B |
$3.74 |
$187,225 |
I/I |
50,000 |
11,052,277 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2017-09-13 |
4 |
B |
$4.13 |
$206,465 |
I/I |
50,000 |
11,102,277 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2017-12-07 |
4 |
B |
$4.77 |
$238,730 |
I/I |
50,000 |
11,182,277 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2017-12-08 |
4 |
B |
$4.92 |
$246,185 |
I/I |
50,000 |
11,232,277 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2017-12-11 |
4 |
B |
$4.96 |
$248,225 |
I/I |
50,000 |
11,282,277 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2017-12-12 |
4 |
B |
$5.40 |
$269,765 |
I/I |
50,000 |
11,332,277 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2017-12-13 |
4 |
B |
$5.57 |
$278,570 |
I/I |
50,000 |
11,382,277 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2014-10-08 |
4 |
B |
$17.50 |
$1,300,005 |
I/I |
74,286 |
6,732,277 |
2.25 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2014-03-25 |
4 |
B |
$17.00 |
$1,552,015 |
I/I |
91,295 |
1,532,560 |
2.1 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
I/I |
144,773 |
144,773 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
10% Owner |
– – • |
2014-09-22 |
4 |
B |
$15.00 |
$2,250,000 |
I/I |
150,000 |
1,771,688 |
1.5 |
- |
|
| ANNX |
Annexon, Inc. |
Director |
– • – |
2020-07-28 |
4 |
B |
$17.00 |
$3,400,000 |
I/I |
200,000 |
1,954,978 |
2.1 |
- |
|
| ANNX |
Annexon, Inc. |
Director |
– • • |
2023-12-26 |
4 |
B |
$2.88 |
$1,008,000 |
I/I |
350,000 |
7,406,024 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2014-04-23 |
4 |
B |
$12.00 |
$4,331,592 |
I/I |
360,966 |
6,643,485 |
2.25 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2015-10-28 |
4 |
B |
$5.50 |
$2,200,000 |
I/I |
400,000 |
7,132,277 |
2.25 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2015-04-22 |
4 |
B |
$8.25 |
$3,465,000 |
I/I |
420,000 |
2,002,560 |
2.1 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2018-09-14 |
4 |
S |
$0.36 |
$160,384 |
I/I |
(447,500) |
7,044,777 |
0 |
- |
|
91 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
